Lymphocytic Colitis: Clinical Trials

1 trial for Lymphocytic Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Lymphocytic Colitis: new trials by email Literature Review of Lymphocytic Colitis trials Research Report on Lymphocytic Colitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
Placebo, Budesonide - Lymphocytic Colitis, Diarrhea
Phase 2 / Phase 3TerminatedMayo Clinic162003-06-012021-11-02

Narrower conditions

Colitis, Lymphocytic (1)  ·  Diarrhea (1)

Broader conditions

Colitis (1)  ·  Colitis, Microscopic (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Budesonide (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Darrell S. Pardi, M.D. (1)

NIH funding

UL1RR024150 (1)